logo

For the Inventor, By the Inventor

Cheam, United Kingdom

J Oliver Dolly

This inventor holds 14 USPTO granted patents and 5 EPO patents, primarily in Neurotoxin Engineering. Top assignee: Allergan, Inc.. Active years: 2006-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Oliver Dolly. Retrieved from https://idiyas.com/inventor/j-oliver-dolly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14

% Patents Active = 21.4

 

Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 342(Granted Patents)


Location History:

  • Cheam, GB (2006 - 2012)
  • Portmarnock, IE (2010 - 2012)

Company Filing History:

goldMedal14 out of 2,287 
 
Allergan, Inc.
 patents

Years Active: 2006-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Clostridial Toxins
Recombinant Neurotoxins
Therapeutic Applications
Activatable Toxins
Biotechnology
Genetic Engineering
Protein Design
Pharmaceutical Development
Targeted Therapy
Neurobiology
Toxin Modulation
14 patents (USPTO):Explore Patents
1. 8273358 - Activatable clostridial toxins (2012-09-25),
2. 8211671 - Activatable recombinant neurotoxins (2012-07-03),
3. 8119370 - Activatable recombinant neurotoxins (2012-02-21),
4. 8071110 - Activatable clostridial toxins (2011-12-06),
5. 8003351 - Activatable recombinant neurotoxins (2011-08-23),
6. 7985411 - Activatable recombinant neurotoxins (2011-07-26),
7. 7959933 - Activatable recombinant neurotoxins (2011-06-14),
8. 7897157 - Activatable clostridial toxins (2011-03-01),
9. 7749514 - Activatable clostridial toxins (2010-07-06),
10. 7740868 - Activatable clostridial toxins (2010-06-22),
11. 7709228 - Activatable recombinant neurotoxins (2010-05-04),
12. 7422877 - Activatable recombinant neurotoxins (2008-09-09),
13. 7419676 - Activatable recombinant neurotoxins (2008-09-02),
14. 7132259 - Activatable recombinant neurotoxins (2006-11-07),

Title: J Oliver Dolly: Innovator in Neurotoxin Research

Introduction

J Oliver Dolly is a prominent inventor based in Cheam, GB. He has made significant contributions to the field of neurotoxin research, holding a total of 14 patents. His work focuses on the development of activatable clostridial toxins and recombinant neurotoxins, which have important applications in medicine.

Latest Patents

Dolly's latest patents include compositions comprising activatable recombinant neurotoxins and polypeptides derived from them. These inventions also encompass nucleic acids encoding such polypeptides, along with methods for producing these polypeptides and nucleic acids. His innovative approach has the potential to advance therapeutic options in various medical fields.

Career Highlights

Throughout his career, J Oliver Dolly has been associated with Allergan, Inc., where he has furthered his research and development efforts. His expertise in neurotoxin technology has positioned him as a leader in this specialized area of study.

Collaborations

Dolly has collaborated with notable colleagues, including Yan Li and Kuo Chion Chan, to enhance the scope and impact of his research. These partnerships have contributed to the advancement of knowledge in neurotoxin applications.

Conclusion

J Oliver Dolly's innovative work in the field of neurotoxin research has led to significant advancements and numerous patents. His contributions continue to shape the landscape of medical science and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…